VAERS reports by lot

Merck HPV lot 0152X: VAERS reports

44 VAERS reports list lot 0152X as a Merck HPV vaccine, received between 2008-04-21 and 2019-07-23. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
44
Reports
36%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Dermatological (non-injection-site)1816%
Neurological1715%
General / Systemic (non-local)1614%
Gastrointestinal1312%
Injection-site / Local reaction1110%
Cardiac / Cardiovascular109%
Allergic / Anaphylactic98%
Musculoskeletal87%
Reproductive / Menstrual76%
Thrombotic / Hematological11%
Autoimmune / Immune-mediated11%
Respiratory11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York8
Florida4
Georgia3
Pennsylvania3
Michigan2
Missouri2
Illinois2
New Jersey1
California1
Colorado1
Maine1
Alabama1

Reports by month received

2008-041
2008-054
2008-067
2008-077
2008-087
2008-095
2008-105
2008-111
2009-022
2009-032
2010-091
2011-081
2019-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.